Toward full-sequence de novo protein design with flexible templates for human beta-defensin-2

Biophysical Journal

Volumn 94, Issue 2, 2008, Pages 584-599

  Ho, Ki Fung ^a   Floudas, Christodoulos A ^a   Taylor, Martin S ^b   Zhang, Li ^c   Morikis, Dimitrios ^d  

^a Princeton University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California Riverside   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CYSTEINE; BETA DEFENSIN; DEFB4 PROTEIN, HUMAN; UNCLASSIFIED DRUG; WATER;

AMINO ACID SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; INNATE IMMUNITY; MATHEMATICAL MODEL; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY; CHEMICAL STRUCTURE; CHEMISTRY; CLUSTER ANALYSIS; COMPUTER SIMULATION; DRUG DESIGN; HUMAN; METABOLISM; MUTATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BETA-DEFENSINS; CLUSTER ANALYSIS; COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; WATER;

EID: 38349008761     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.107.110627     Document Type: Article

References (95)

1. Fernandez-Lopez, S., H. Kim, E. C. Choi, M. Delgado, J. R. Granja, A. Khasanov, K. Kraehenbuehl, G. Long, D. A. Weinberger, K. M. Wilcoxen, and M. R. Ghadiri. 2001. Antibacterial agents based on the cyclic D,L-α-peptide architecture. Nature. 412:452-455.
2. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piranino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 414:454-457.
3. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature. 415:389-395.
4. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nature. 3:710-720.
5. Mygind, P. H., R. L. Fischer, K. M. Schnorr, M. T. Hansen, C. P. Sönksen, S. Ludvigsen, D. Raventós, S. Buskov, B. Christensen, L. D. Maria, O. Taboureau, D. Yaver, S. G. Elvig-Jørgensen, M. V. Sørensen, B. E. Christensen, S. Kjærulff, N. Frimodt-Moller, R. I. Lehrer, M. Zasloff, and H.-H. Kristensen. 2005. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature. 437:975-980.
6. Loose, C., K. Jensen, I. Rigoutsos, and G. Stephanopoulos. 2006. A linguistic model for the rational design of antimicrobial peptides. Nature. 443:867-869.
7. Hancock, R. E., and A. Patrzykat. 2002. A Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2:79-83.
8. Niyonsaba, F., H. Ogawa, and I. Nagaoka. 2004. Human β-defensin-2 functions as a chemotactic agent for tumor necrosis factor-α-treated human neutrophils. Immunology. 111:273-281.
9. Schröder, J., and J. Harder. 1999. Molecules in focus: human β-defensin-2. Int. J. Biochem. Cell Biol. 31:645-651.
10. Ganz, T., and R. I. Lehrer. 1994. Defensins. Curr. Opin. Immunol. 6:584-589.
11. Dale, B., and S. Krisanaprakornkit. 2001. Defensin antimicrobial peptides in the oral cavity. J. Oral Pathol. Med. 30:321-327.
12. Dunsche, A., Y. Acil, R. Siebert, J. Harder, J. M. Schroder, and S. Jepsen. 2001. Expression profile of human defensins and antimicrobial proteins in oral tissues. J. Oral Pathol. Med. 30:154-158.
13. Harder, J., J. Bartels, E. Christophers, and J.-M. Schröder. 1997. A peptide antibiotic from human skin. Nature. 387:861.
14. Lehrer, R. I., T. Ganz, and M. E. Selsted. 1991. Defensins: endogenous antibiotic peptides of animal cells. Cell. 64:229-230.
15. Ouellette, A. J., and M. E. Selsted. 1996. Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J. 10:1280-1289.
16. Yadava, P., C. Zhang, J. Sun, and J. A. Hughes. 2006. Antimicrobial activities of human β-defensins against Bacillus species. Int. J. Antimicrob. Agents. 28:132-137.
17. Klepeis, J. L., C. A. Floudas, D. Morikis, C. G. Tsokos, E. Argyropoulos, L. Spruce, and J. D. Lambris. 2003. Integrated structural, computational and experimental approach for lead optimization: design of compstatin variants with improved activity. J. Am. Chem. Soc. 125:8422-8423.
18. Klepeis, J. L., C. A. Floudas, D. Morikis, C. G. Tsokos, and J. D. Lambris. 2004. Design of peptide analogs with improved activity using a novel de novo protein design approach. Ind. Eng. Chem. Res. 43: 3817-3826.
19. Fung, H. K., S. Rao, C. A. Floudas, O. Prokopyev, P. M. Pardalos, and F. Rendl. 2005. Computational comparison studies of quadratic assignment like formulations for the in silico sequence selection problem in de novo protein design. J. Comb. Optim. 10:41-60.
20. Fung, H. K., M. S. Taylor, and C. A. Floudas. 2007. Novel formulations for the sequence selection problem in de novo protein design with flexible templates. Optim. Methods Software. 22:51-71.
21. Mineshiba, F., S. Takashiba, J. Mineshiba, K. Matsuura, and S. Kokeguchi. 2003. Antibacterial activity of synthetic human β-defensin-2 against periodontal bacteria. J. Int. Acad. Periodontol. 5:35-40.
22. Huang, G. T., H. B. Zhang, C. Yin, and S. H. Park. 2004. Human beta-defensin-2 gene transduction of dental pulp cells: a model for pulp antimicrobial gene therapy. Int. J. Oral Biol. 29:7-12.
23. Matsuzaki, K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta. 1462:1-10.
24. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell nonselective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:55-70.
25. Yang, L., T. M. Weiss, R. I. Lehrer, and H. W. Huang. 2000. Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys. J. 79:2002-2009.
26. Yang, D., A. Biragyn, D. M. Hoover, J. Lubkowski, and J. J. Oppenheim. 2004. Multiple Roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22:181-215.
27. Klotman, M. E., and T. L. Chang. 2006. Defensins in innate antiviral immunity. Nature Rev. Immunol. 6:447-456.
28. Quiñones Mateu, M. E., M. M. Lederman, Z. Feng, B. Chakraborty, J. Weber, H. R. Rangel, M. L. Marotta, M. Mirza, B. Jiang, P. Kiser, K. Medvik, S. F. Sieg, and A. Weinberg. 2003. Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication. AIDS. 17:F39-F48.
29. Sun, L., C. M. Finnegan, T. Kish-Catalone, R. Blumenthal, P. Garzino-Demo, G. M. L. T. Maggiore, S. Berrone, C. Kleinman, Z. Wu, S. Abdelwahab, W. Lu, and A. Garzino-Demo. 2005. Human β-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J. Virol. 79:14318-14329.
30. Yin, C., H. N. Dang, F. Gazor, and G. T.-J. Huang. 2006. Mouse salivary glands and human β-defensin-2 as a study model for antimicrobial gene therapy: technical considerations. Int. J. Antimicrob. Agents. 28:352-360.
31. Fung, H. K., and C. A. Floudas. 2007. Computational de novo peptide and protein design: rigid templates versus flexible templates. Ind. Eng. Chem. Res. Accepted for publication.
32. Floudas, C. A., H. K. Fung, S. R. McAllister, M. Mönnigmann, and R. Rajgaria. 2006. Advances in protein structure prediction and de novo protein design: a review. Chem. Eng. Sci. 61:966-988.
33. Desmet, J., M. D. Maeyer, B. Hazes, and I. Lasters. 1992. The dead-end elimination theorem and its use in side-chain positioning. Nature. 356:539-542.
34. Goldstein, R. 1994. Efficient rotamer elimination applied to protein side-chains and related spin glasses. Biophys. J. 66:1335-1340.
35. Pierce, N., J. Spriet, J. Desmet, and S. Mayo. 2000. Conformational splitting: a more powerful criterion for dead-end elimination. J. Comput. Chem. 21:999-1009.
36. Wernisch, L., S. Hery, and S. Wodak. 2000. Automatic protein design with all atom force-fields by exact and heuristic optimization. J. Mol. Biol. 301:713-736.
37. Looger, L., and H. Hellinga. 2001. Generalized dead-end elimination algorithms make large-scale protein side-chain structure prediction tractable: implications for protein design and structural genomics. J. Mol. Biol. 307:429-445.
38. Gordon, B., G. Hom, S. Mayo, and N. Pierce. 2003. Exact rotamer optimization for protein design. J. Comput. Chem. 24:232-243.
39. Koehl, P., and M. Delarue. 1994. Application of a self-consistent mean field theory to predict protein side-chains conformation and estimate their conformational entropy. J. Mol. Biol. 239:249-275.
40. Zou, J. M., and J. Saven. 2000. Statistical theory of combinatorial libraries of folding proteins: energetic discrimination of a target structure. J. Mol. Biol. 296:281-294.
41. Kono, H., and J. Saven. 2001. Statistical theory of protein combinatorial libraries: packing interactions, backbone flexibility, and the sequence variability of a main-chain structure. J. Mol. Biol. 306:607-628.
42. Koehl, P., and M. Levitt. 1999. De novo protein design I. In search of stability and specificity. J. Mol. Biol. 293:1161-1181.
43. Dantas, G., B. Kuhlman, D. Callender, M. Wong, and D. Baker. 2003. A large scale test of computational protein design: folding and stability of nine completely redesigned globular proteins. J. Mol. Biol. 332:449-460.
44. Zou, J., and J. Saven. 2003. Using self-consistent fields to bias Monte Carlo methods with applications to designing and sampling protein sequences. J. Chem. Phys. 118:3843-3854.
45. Tuffery, P., C. Etchebest, S. Hazout, and R. Lavery. 1991. A new approach to the rapid determination of protein side chain conformations. J. Biomol. Struct. Dyn. 8:1267-1289.
46. Su, A., and S. Mayo. 1997. Coupling backbone flexibility and amino acid sequence selection in protein design. Protein Sci. 6:1701-1707.
47. Desjarlais, J., and T. Handel. 1999. Side chain and backbone flexibility in protein core design. J. Mol. Biol. 290:305-318.
48. Raha, K., A. Wollacott, M. Italia, and J. Desjarlais. 2000. Prediction of amino acid sequence from structure. Protein Sci. 9:1106-1119.
49. Ross, S., C. Sarisky, A. Su, and S. Mayo. 2001. Designed protein G core variants fold to native-like structures: sequence selection by ORBIT tolerates variation in backbone specification. Protein Sci. 10:450-454.
50. Larson, S. M., J. L. England, J. R. Desjarlais, and V. S. Pande. 2002. Thoroughly sampling sequence space: large-scale protein design of structural ensembles. Protein Sci. 11:2804-2813.
51. Larson, S. M., A. Garg, J. R. Desjarlais, and V. S. Pande. 2003. Increased detection of structural templates using alignments of designed sequences. Proteins. 51:390-396.
52. Kraemer-Pecore, C., J. Lecomte, and J. Desjarlais. 2003. A de novo redesign of the WW domain. Protein Sci. 12:2194-2205.
53. Kuhlman, B., G. Dantae, G. Ireton, G. Verani, B. Stoddard, and D. Baker. 2003. Design of a novel globular protein fold with atomic-level accuracy. Science. 302:1364-1368.
54. Saunders, C. T., and D. Baker. 2005. Recapitulation of protein family divergence using flexible backbone protein design. J. Mol. Biol. 346:631-644.
55. Harbury, P., B. Tidor, T. Alber, and P. Kim. 1995. Repacking protein cores with backbone freedom: structure prediction for coiled coils. Proc. Natl. Acad. Sci. USA. 92:8408-8412.
56. Harbury, P., J. Plecs, B. Tidor, T. Alber, and P. Kim. 1998. High-resolution protein design with backbone freedom. Science. 282:1462-1467.
57. Plecs, J., P. B. Harbury, P. Kim, and T. Alber. 2004. Structural test of the parameterized-backbone method for protein design. J. Mol. Biol. 342:289-297.
58. Floudas, C. A., H. K. Fung, D. Morikis, M. S. Taylor, and L. Zhang. 2007. Overcoming the key challenges in de novo protein design: enhancing computational efficiency and incorporating true backbone flexibility. In Modeling of Biosystems: An Interdisciplinary Approach. R. Mondaini, editor. Springer Verlag., Heidelberg.
59. Krishnakumari, V., S. Singh, and R. Nagaraj. 2006. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human β-defensins 1-3. Peptides. 27:2607-2613.
60. Hoover, D., K. Rajashankar, R. Blumenthal, A. Puri, J. Oppenheim, O. Chertov, and J. Lubkowski. 2000. The structure of human β-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275:32911-32918.
61. Pierce, N., and E. Winfree. 2002. Protein design is NP-hard. Protein Eng. 15:779-782.
62. Cornell, W. D., P. Cieplak, C. I. Bayly, I. R. Gould, K. M. Merz, D. M. Ferguson, D. C. Spellmeyer, T. Fox, J. W. Caldwell, and P. A. Kollman. 1995. A 2nd generation force-field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117:5179-5197.
63. Guntert, P., C. Mumenthaler, and K. Wuthrich. 1997. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273:283-298.
64. Guntert, P. 2004. Automated NMR structure calculation with CYANA. J. Mol. Biol. 278:353-378.
65. Loose, C., J. Klepeis, and C. Floudas. 2004. A new pairwise folding potential based on improved decoy generation and side chain packing. Proteins Struct. Funct. Bioinformatics. 54:303-314.
66. Tobi, D., and R. Elber. 2000. Distance-dependent pair potential for protein folding: results from linear optimization. Proteins Struct. Funct. Bioinformatics. 41:40-46.
67. Tobi, D., G. Shafran, N. Linial, and R. Elber. 2000. On the design and analysis of protein folding potentials. Proteins Struct. Funct. Bioinformatics. 40:71-85.
68. CPLEX. 1997. Using the CPLEX Callable Library. ILOG, Sunnyvale, CA.
69. α distance dependent force field based on a high quality decoy set. Proteins Struct. Funct. Bioinformatics. 65:726-741.
70. Rajgaria, R., S. R. McAllister, and C. A. Floudas. 2007. Improving the performance of a high resolution distance dependent force field by including protein side chains. Proteins Struct. Funct. Bioinformatics. In press.
71. Floudas, C. A. 2005. Research challenges, opportunities and synergism in systems engineering and computational biology. AIChE J. 51:1872-1884.
72. Klepeis, J. L., C. A. Floudas, D. Morikis, and J. Lambris. 1999. Predicting peptide structures using NMR data and deterministic global optimization. J. Comput. Chem. 20:1354-1370.
73. Klepeis, J. L., and C. A. Floudas. 1999. Free energy calculations for peptides via deterministic global optimization. J. Chem. Phys. 110:7491-7512.
74. Klepeis, J. L., and C. A. Floudas. 2003. Ab initio tertiary structure prediction of proteins. J. Glob. Optim. 25:113-140.
75. Klepeis, J. L., and C. A. Floudas. 2003. Prediction of β-sheet topology and disulfide bridges in polypeptides. J. Comput. Chem. 24:191-208.
76. Klepeis, J., and C. Floudas. 2003. Ab initio tertiary structure prediction of proteins. J. Glob. Optim. 25:113-140.
77. Klepeis, J., and C. Floudas. 2003. ASTRO-FOLD: a combinatorial and global optimization framework for ab initio prediction of three-dimensional structures of proteins from the amino acid sequence. Biophys. J. 85:2119-2146.
78. Androulakis, I., C. Maranas, and C. A. Floudas. 1997. Prediction of oligopeptide conformations via deterministic global optimization. J. Glob. Optim. 11:1-34.
79. Androulakis, I., C. Maranas, and C. A. Floudas. 1995. Alpha BB: a global optimization method for general constrained nonconvex problems. J. Glob. Optim. 7:337-363.
80. McDonald, C., and C. Floudas. 1995. Global optimization for the phase and chemical-equilibrium problem - application to the NRTL equation. Comput. Chem. Eng. 19:1111-1139.
81. Floudas, C., and P. Pardalos. 1995. State-of-the-art in global optimization - computational methods and applications - preface. J. Glob. Optim. 7:113-113.
82. Adjiman, C., I. Androulakis, C. Maranas, and C. A. Floudas. 1996. A global optimization method, αBB, for process design. Computers Chem. Eng. 20:S419-S424 (Suppl. A.).
83. Adjiman, C., I. Androulakis, and C. A. Floudas. 1997. Global optimization of MINLP problems in process synthesis and design. Computers Chem. Eng. 21:S445-S450 (Suppl. S.).
84. Maranas, C., and C. A. Floudas. 1997. Global optimization in generalized geometric programming. Computers Chem. Eng. 21:351-369.
85. Adjiman, C., I. Androulakis, and C. A. Floudas. 1998. A global optimization method, αBB, for general twice-differentiable constrained NPLs. I. Theoretical advances. Computers Chem. Eng. 22:1137-1158.
86. Adjiman, C., I. Androulakis, and C. A. Floudas. 2000. Global optimization of mixed-integer nonlinear problems. AIChE J. 46:1769-1797.
87. Ponder, J. 1998. TINKER, Software Tools for Molecular Design. Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO.
88. García, J., J. Florian, S. Schulz, A. Krause, F. Rodríguez-Jiménez, U. Forssmann, K. Adermann, E. Klüver, C. Vogelmeier, D. Becker, R. Hedrich, W. Forssmann, and R. Bals. 2001. Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity. Cell Tissue Res. 306:257-264.
89. Brooks, B. R., R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan, and M. Karplus. 1983. CHARMM - a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4:187-217.
90. Dominy, B., and C. L. Brooks III. 1999. Development of a Generalized Born model parameterization for proteins and nucleic acids. J. Phys. Chem. 103:3765-3773.
91. Ryckaert, J. P., G. Ciccotti, and H. J. C. Berendsen. 1977. Numerical integration of Cartesian equations of motion of a system with constraints - molecular dynamics of n-alkanes. J. Comput. Phys. 23:327-341.
92. Russ, W. P., and R. Ranganathan. 2002. Knowledge-based potential functions in protein design. Curr. Opin. Struct. Biol. 12:447-452.
93. Hoover, D., O. Chertov, and J. Lubkowski. 2001. The structure of human β-defensin-1. J. Biol. Chem. 276:39021-39026.
94. Dayhoff, M. O., R. M. Schwartz, and B. C. Orcutt. 1978. A model of evolutionary change in proteins. In Atlas of Protein Sequence and Structure, Vol. 5. M. O. Dayhoff, editor. National Biomedical Research Foundation, Washington, DC.
95. Schwartz, R. M., and M. O. Dayhoff. 1978. Matrices for detecting distant relationships. In Atlas of Protein Sequence and Structure, Vol. 5. M. O. Dayhoff, editor. National Biomedical Research Foundation, Washington, DC.